Judge Says Pfizer Heart Drug Copay Program Is A Kickback

By Andrew Karpan (October 1, 2021, 9:18 PM EDT) -- A New York federal judge has found that Pfizer's planned efforts to offer copay assistance to Medicare beneficiaries for a pricey medication that treats a fatal heart condition are in violation of an anti-kickback law.

In a ruling that came down late Thursday, U.S. District Judge Mary Kay Vyskocil threw out a lawsuit Pfizer Inc. lodged against the U.S. Department of Health and Human Services last year in its efforts to market two medications that treat transthyretin amyloid cardiomyopathy, a rare condition affecting the heart muscle, which causes the heart to stiffen and limits its ability to pump blood to the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!